| Tonia L Skakalski, DO | |
|
63 Pitt St, Sharon, PA 16146-2102 | |
| (724) 981-4434 | |
| (724) 981-3736 |
| Full Name | Tonia L Skakalski |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 24 Years |
| Location | 63 Pitt St, Sharon, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013911411 | NPI | - | NPPES |
| 1013091710004 | Medicaid | PA | |
| 0203683 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OS013213 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Butler Memorial Hospital | Butler, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Butler Medical Providers | 7416840160 | 308 |
News Archive
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
New research from UC San Francisco found that 60 percent of the city's homeless and unstably housed women who are HIV-infected or at high risk to become infected have endured a recent experience of some form of violence.
Women who experience early menopause are more likely to have a heart attack or stroke than women whose menopause occurs at a later age, according to a new study by Melissa Wellons, M.D., assistant professor of Medicine in the Vanderbilt Division of Diabetes, Endocrinology and Metabolism.
Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 9 days ago
| Entity Name | Butler Medical Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619493046 PECOS PAC ID: 7416840160 Enrollment ID: O20040205000830 |
News Archive
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
New research from UC San Francisco found that 60 percent of the city's homeless and unstably housed women who are HIV-infected or at high risk to become infected have endured a recent experience of some form of violence.
Women who experience early menopause are more likely to have a heart attack or stroke than women whose menopause occurs at a later age, according to a new study by Melissa Wellons, M.D., assistant professor of Medicine in the Vanderbilt Division of Diabetes, Endocrinology and Metabolism.
Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 9 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902347438 PECOS PAC ID: 2860688728 Enrollment ID: O20170524000169 |
News Archive
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
New research from UC San Francisco found that 60 percent of the city's homeless and unstably housed women who are HIV-infected or at high risk to become infected have endured a recent experience of some form of violence.
Women who experience early menopause are more likely to have a heart attack or stroke than women whose menopause occurs at a later age, according to a new study by Melissa Wellons, M.D., assistant professor of Medicine in the Vanderbilt Division of Diabetes, Endocrinology and Metabolism.
Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tonia L Skakalski, DO 100 Shenango Ave, Sharon, PA 16146-1503 Ph: (724) 981-4434 | Tonia L Skakalski, DO 63 Pitt St, Sharon, PA 16146-2102 Ph: (724) 981-4434 |
News Archive
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
New research from UC San Francisco found that 60 percent of the city's homeless and unstably housed women who are HIV-infected or at high risk to become infected have endured a recent experience of some form of violence.
Women who experience early menopause are more likely to have a heart attack or stroke than women whose menopause occurs at a later age, according to a new study by Melissa Wellons, M.D., assistant professor of Medicine in the Vanderbilt Division of Diabetes, Endocrinology and Metabolism.
Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs.
New data presented at the 2016 San Antonio Breast Cancer Symposium (SABCS) demonstrate that analyzing tumor biology with the Oncotype DX test can identify patients unlikely to benefit from chemotherapy prior to breast cancer surgery (neoadjuvant setting) and guide treatment decisions without compromising outcomes.
› Verified 9 days ago
John Patrick Gallagher, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 63 Pitt St, Sharon, PA 16146 Phone: 724-981-4434 Fax: 724-981-3736 |